Andrew S. Davis - Feb 1, 2023 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Feb 1, 2023
Transactions value $
-$333,058
Form type
4
Date filed
2/3/2023, 06:19 PM
Previous filing
Jan 4, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $31.9K +6.75K +6.88% $4.73 105K Feb 1, 2023 Direct F1
transaction SILK Common Stock Sale -$365K -6.75K -6.43% $54.05 98.2K Feb 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -6.75K -10.96% $0.00 54.9K Feb 1, 2023 Common Stock 6.75K $4.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2 All of the shares subject to this option are fully vested and exercisable as of the date hereof.